Active and Placebo Controlled Study to Test the Efficacy and Safety of an Aspirin-Lidocaine Lozenge in the Symptomatic Treatment of Sore Throat Associated With a Common Cold

PHASE3CompletedINTERVENTIONAL
Enrollment

1,088

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

May 28, 2005

Study Completion Date

May 28, 2005

Conditions
Common ColdPharyngitisTonsillitis
Interventions
DRUG

Acetylsalicylic acid (Aspirin, BAYE4465) & Lidocain

Single oral application of a fixed combination of Aspirin and Lidocain (as one lozenge)

DRUG

Acetylsalicylic Acid (Aspirin, BAYE4465)

Single oral application of Aspirin (as lozenge)

DRUG

Lidocain

Single oral application of Lidocain (as lozenge)

DRUG

Placebo

Single oral application of Placebo (as lozenge)

Trial Locations (19)

91011

Luhansk

91055

Luhansk

105064

Moscow

114765

Moscow

117321

Moscow

117342

Moscow

117393

Moscow

117418

Moscow

117421

Moscow

117485

Moscow

117513

Moscow

117574

Mocow

117588

Moscow

127299

Moscow

630099

Novosibirsk

02091

Kiev

02222

Kiev

02232

Kiev

03049

Kiev

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY